Award
Purchase Order #75N98026P00519
Purchase Order for Advanced DNA Sequencing Technology from BioLegend, Inc.
Buyer
National Institutes of Health
Award Amount
$22,756.60
Ceiling
$22,756.60
Awarded
May 13, 2026
Period of Performance
May 13, 2026 – Nov 12, 2026
Identifier
75N98026P00519
NAICS
325414
This award is a purchase order contract for acquiring the Mission Bio Tapestri single cell DNA sequencing system, an advanced biotechnology tool. The recipient, BioLegend, Inc., specializes in biotechnology products and services that facilitate cellular analysis and support research and clinical applications. This multi-month contract enables the delivery of cutting-edge sequencing equipment to a designated facility in San Diego, California, enhancing the agency’s genomic research capabilities critical for biomedical studies and potential clinical diagnostics. The procurement was conducted through a competitive bidding process to ensure the agency’s science and technology requirements were effectively met. Spanning approximately six months, this agreement ensures timely deployment and utilization of innovative sequencing technology to advance the agency’s mission. No subcontractors or previous related contracts are associated with this award.
Description
MISSION BIO TAPESTRI SINGLE CELL DNA SEQUENCING BIOLEGEND INC:1135351 [26-004813]